Skip to main content
Top
Published in: Infection 2/2016

01-04-2016 | Case Report

Recurrent seizures during acute acquired toxoplasmosis in an immunocompetent traveller returning from Africa

Authors: Anna Beltrame, Sergio Venturini, Giovanni Crichiutti, Valeria Meroni, Dora Buonfrate, Matteo Bassetti

Published in: Infection | Issue 2/2016

Login to get access

Abstract

Introduction

We report an unusual case of acute acquired toxoplasmosis (AAT) presenting as lymphadenopathy and recurrent seizures in an immunocompetent 15-year-old boy.

Materials and methods

The patient reported an 18-day vacation to Africa (Ethiopia), 39 days prior to the first seizure. Electroencephalogram (EEG) showed sporadic single-spike or sharp-wave paroxysms and the magnetic resonance imaging (RMI) of the brain was negative. The serology for T. gondii was compatible with an acute infection defined as positive for both toxoplasma-specific IgG and IgM and a low avidity (6 %), confirmed by a reference laboratory. The patient reported other two episodes of seizures, occurring 7 days apart. He was treated with pyrimethamine plus sulfadiazine and leucovorin for 4 weeks, with an improvement of lymphadenitis and normalization of EEG. After 5 months, new seizures were reported and a diagnosis of epilepsy was done. Toxoplasma polymerase chain reaction (PCR) of cerebrospinal fluid (CSF) and blood were negative. A treatment with valproic acid was started, obtaining control of the neurological disease.

Conclusion

Awareness of this neurologic manifestation by clinicians is required, also in immunocompetent patients. The relationship between toxoplasmosis and recurrent seizure needs to be investigated by new studies.
Literature
2.
go back to reference Galli-Tsinopoulou A, Kyrgios I, Giannopoulou EZ, Gourgoulia S, Maggana I, Katechaki E, et al. Acquired Toxoplasmosis accompanied by facial nerve palsy in an immunocompetent 5-year-old child. J Child Neur. 2010;25:1525–8.CrossRef Galli-Tsinopoulou A, Kyrgios I, Giannopoulou EZ, Gourgoulia S, Maggana I, Katechaki E, et al. Acquired Toxoplasmosis accompanied by facial nerve palsy in an immunocompetent 5-year-old child. J Child Neur. 2010;25:1525–8.CrossRef
3.
go back to reference Neves Ede S, Kropf A, Bueno WF, Bonna IC, Curi AL, Amendoeira, et al. Disseminated toxoplasmosis: an atypical presentation in an immunocompetent patient. Trop Doct. 2011;41:59-60. Neves Ede S, Kropf A, Bueno WF, Bonna IC, Curi AL, Amendoeira, et al. Disseminated toxoplasmosis: an atypical presentation in an immunocompetent patient. Trop Doct. 2011;41:59-60.
4.
go back to reference Undseth O, Gerlyng P, Goplen AK, Holetr E, Von der Lippe E, Dunlop O. Primary toxoplasmosis with critical illness and multi-organ failure in an immunocompetent young man. Scand J Infect Dis. 2014;46:58–62.CrossRefPubMed Undseth O, Gerlyng P, Goplen AK, Holetr E, Von der Lippe E, Dunlop O. Primary toxoplasmosis with critical illness and multi-organ failure in an immunocompetent young man. Scand J Infect Dis. 2014;46:58–62.CrossRefPubMed
5.
go back to reference Demar M, Hommel D, Djossou F, Peneau C, Boukhari R, Louvel D, et al. Acute toxoplasmosis in immunocompetent patients hospitalized in an intensive care unit in French Guiana. Clin Microbiol Infect. 2012;18:E221–31.CrossRefPubMed Demar M, Hommel D, Djossou F, Peneau C, Boukhari R, Louvel D, et al. Acute toxoplasmosis in immunocompetent patients hospitalized in an intensive care unit in French Guiana. Clin Microbiol Infect. 2012;18:E221–31.CrossRefPubMed
6.
go back to reference Carme B, Demar M, Ajzenberg D. Darde’ML. Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii, French Guiana. Emerg Infect Dis. 2009;15:656–8.CrossRefPubMedPubMedCentral Carme B, Demar M, Ajzenberg D. Darde’ML. Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii, French Guiana. Emerg Infect Dis. 2009;15:656–8.CrossRefPubMedPubMedCentral
7.
go back to reference Sepulveda-Arias J, Gomez-Marin JE, Bobic B, Naranjo-Galvis CA, Djurkovic-Djakovic O. Toxoplasmosis as a travel risk. Travel Med Infect Dis. 2014;1–10. Sepulveda-Arias J, Gomez-Marin JE, Bobic B, Naranjo-Galvis CA, Djurkovic-Djakovic O. Toxoplasmosis as a travel risk. Travel Med Infect Dis. 2014;1–10.
8.
go back to reference Pomares C, Ajzenberg D, Bornard L, Bernardin G, Hasseine L, Darde ML, et al. Toxoplasmosis and horse meat. France. Emerg Infect Dis. 2011;17:1327–8.CrossRefPubMed Pomares C, Ajzenberg D, Bornard L, Bernardin G, Hasseine L, Darde ML, et al. Toxoplasmosis and horse meat. France. Emerg Infect Dis. 2011;17:1327–8.CrossRefPubMed
9.
go back to reference Sobanski V, Ajzenberg D, Delhaes L, Bautin N, Just N. Severe toxoplasmosis in immunocompetent hosts: be aware of atypical strains. Am J Respir Crit Care Med. 2013;187:1143–5.CrossRefPubMed Sobanski V, Ajzenberg D, Delhaes L, Bautin N, Just N. Severe toxoplasmosis in immunocompetent hosts: be aware of atypical strains. Am J Respir Crit Care Med. 2013;187:1143–5.CrossRefPubMed
11.
go back to reference Stommel EW, Seguin R, Thadani V, Schwartzman JD, Gilbert K, Ryan KA, et al. Cryptogenic epilepsy: an infectious etiology? Epilepsia. 2001;42:436–8.CrossRefPubMed Stommel EW, Seguin R, Thadani V, Schwartzman JD, Gilbert K, Ryan KA, et al. Cryptogenic epilepsy: an infectious etiology? Epilepsia. 2001;42:436–8.CrossRefPubMed
12.
go back to reference Ngoungou EB, Bhalla D, Nzoghe A, Dardé ML, Preux PM. Toxoplasmosis and epilepsy—systemic review and meta-analysis. PLoS Negl Trop Dis. 2015;19:e0003525.CrossRef Ngoungou EB, Bhalla D, Nzoghe A, Dardé ML, Preux PM. Toxoplasmosis and epilepsy—systemic review and meta-analysis. PLoS Negl Trop Dis. 2015;19:e0003525.CrossRef
14.
go back to reference Velmurugan GV, Dubey JB, Su C. Genotyping studies of Toxoplasma gondii isolated from Africa revealed that the archetypal clonal lineages predominate as in North America and Europe. Vet Parasitol. 2008;155:314–8.CrossRefPubMed Velmurugan GV, Dubey JB, Su C. Genotyping studies of Toxoplasma gondii isolated from Africa revealed that the archetypal clonal lineages predominate as in North America and Europe. Vet Parasitol. 2008;155:314–8.CrossRefPubMed
15.
go back to reference Mercier A, Devillard S, Ngoubangoye B, Bonnabau H, Banuls AL, Durant P, et al. Additional haplogroups of Toxoplasma gondii out of Africa: population structure and mouse-virulence of strains from Gabon. PLoS Negl Trop Dis. 2010;4:e876.CrossRefPubMedPubMedCentral Mercier A, Devillard S, Ngoubangoye B, Bonnabau H, Banuls AL, Durant P, et al. Additional haplogroups of Toxoplasma gondii out of Africa: population structure and mouse-virulence of strains from Gabon. PLoS Negl Trop Dis. 2010;4:e876.CrossRefPubMedPubMedCentral
16.
go back to reference Maubon D, Ajzenberg D, Brenier-Pinchart MP, Dardé ML, Pelloux H. What are the respective host and parasite contributions to toxoplasmosis? Trends Parasitol. 2008;24:299–303.CrossRefPubMed Maubon D, Ajzenberg D, Brenier-Pinchart MP, Dardé ML, Pelloux H. What are the respective host and parasite contributions to toxoplasmosis? Trends Parasitol. 2008;24:299–303.CrossRefPubMed
Metadata
Title
Recurrent seizures during acute acquired toxoplasmosis in an immunocompetent traveller returning from Africa
Authors
Anna Beltrame
Sergio Venturini
Giovanni Crichiutti
Valeria Meroni
Dora Buonfrate
Matteo Bassetti
Publication date
01-04-2016
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 2/2016
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-015-0821-7

Other articles of this Issue 2/2016

Infection 2/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.